APO Research
Talk to an analyst

APO RESEARCH · REPORT

Calming Aids for Dogs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Calming Aids for Dogs Market Outlook and Growth Opportunities 2026

23 December 2025215 pages

Choose your research edition.

Industry ResearchCalming Aids for Dogs Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Calming Aids for Dogs Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Calming Aids for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Calming Aids for Dogs Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Calming Aids for Dogs Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Calming Aids for Dogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Calming Aids for Dogs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Calming Aids for Dogs market include Zoetis, Shangrao Chunyu Technology, Shandong Youmi Le Health Technology, Zatural, Wild One, Vetoquinol, ThunderEase, This Dog's Life and The Anxious Pet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Calming Aids for Dogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Calming Aids for Dogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Calming Aids for Dogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Calming Aids for Dogs market size, projected growth trends, production technologies, key applications, and end-use industries.

Calming Aids for Dogs Segment by Company

Zoetis

Shangrao Chunyu Technology

Shandong Youmi Le Health Technology

Zatural

Wild One

Vetoquinol

ThunderEase

This Dog's Life

The Anxious Pet

Purina

Primo Pup

PetHonesty

Pet Remedy

Penelope's Bloom

NaturVet

Merck Animal Health

Maxxidog

Kradle

Koi CBD

King Kanine

Heavenly Hounds

FOMO Bones

Extract Labs

ElleVet Sciences

Elanco

Dr. Harvey’s

Ceva

Boehringer Ingelheim

Ark Naturals

Adaptil

Calming Aids for Dogs Segment by Type

Calming Collars

Calming Supplements

Pheromone Sprays

Anxiety Vests

Calming Aids for Dogs Segment by Application

Pet Shop

Pet Hospitals and Clinics

Household

Others

Calming Aids for Dogs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Calming Aids for Dogs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Calming Aids for Dogs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Calming Aids for Dogs significant trends, drivers, influence factors in global and regions.

6. To analyze Calming Aids for Dogs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming Aids for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calming Aids for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming Aids for Dogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Calming Aids for Dogs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Calming Aids for Dogs industry.

Chapter 3: Detailed analysis of Calming Aids for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Calming Aids for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Calming Aids for Dogs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Calming Aids for Dogs Industry Trends Table 2. Calming Aids for Dogs Industry Drivers Table 3. Calming Aids for Dogs Industry Opportunities and Challenges Table 4. Calming Aids for Dogs Industry Restraints Table 5. Global Calming Aids for Dogs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Calming Aids for Dogs Revenue Share by Company (2021-2026) Table 7. Global Calming Aids for Dogs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Calming Aids for Dogs Sales Volume Share by Company (2021-2026) Table 9. Global Calming Aids for Dogs Average Price (USD/unit) of Company (2021-2026) Table 10. Global Calming Aids for Dogs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Calming Aids for Dogs Key Company Manufacturing Base & Headquarters Table 12. Global Calming Aids for Dogs Company, Product Type & Application Table 13. Global Calming Aids for Dogs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Calming Aids for Dogs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Calming Collars Table 18. Significant Companies of Calming Supplements Table 19. Significant Companies of Pheromone Sprays Table 20. Significant Companies of Anxiety Vests Table 21. Global Calming Aids for Dogs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Calming Aids for Dogs Sales Volume by Type (2021-2026) & (k units) Table 23. Global Calming Aids for Dogs Sales Volume by Type (2027-2032) & (k units) Table 24. Global Calming Aids for Dogs Sales Volume Share by Type (2021-2026) Table 25. Global Calming Aids for Dogs Sales Volume Share by Type (2027-2032) Table 26. Global Calming Aids for Dogs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Calming Aids for Dogs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Calming Aids for Dogs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Calming Aids for Dogs Sales Value Share by Type (2021-2026) Table 30. Global Calming Aids for Dogs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pet Shop Table 32. Significant Companies of Pet Hospitals and Clinics Table 33. Significant Companies of Household Table 34. Significant Companies of Others Table 35. Global Calming Aids for Dogs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Calming Aids for Dogs Sales Volume by Application (2021-2026) & (k units) Table 37. Global Calming Aids for Dogs Sales Volume by Application (2027-2032) & (k units) Table 38. Global Calming Aids for Dogs Sales Volume Share by Application (2021-2026) Table 39. Global Calming Aids for Dogs Sales Volume Share by Application (2027-2032) Table 40. Global Calming Aids for Dogs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Calming Aids for Dogs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Calming Aids for Dogs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Calming Aids for Dogs Sales Value Share by Application (2021-2026) Table 44. Global Calming Aids for Dogs Sales Value Share by Application (2027-2032) Table 45. Global Calming Aids for Dogs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Calming Aids for Dogs Sales by Region (2021-2026) & (k units) Table 47. Global Calming Aids for Dogs Sales Market Share by Region (2021-2026) Table 48. Global Calming Aids for Dogs Sales by Region (2027-2032) & (k units) Table 49. Global Calming Aids for Dogs Sales Market Share by Region (2027-2032) Table 50. Global Calming Aids for Dogs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Calming Aids for Dogs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Calming Aids for Dogs Sales Value Share by Region (2021-2026) Table 53. Global Calming Aids for Dogs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Calming Aids for Dogs Sales Value Share by Region (2027-2032) Table 55. Global Calming Aids for Dogs Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Calming Aids for Dogs Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Calming Aids for Dogs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Calming Aids for Dogs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 60. Global Calming Aids for Dogs Sales Market Share by Country (2021-2026) Table 61. Global Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 62. Global Calming Aids for Dogs Sales Market Share by Country (2027-2032) Table 63. Global Calming Aids for Dogs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Calming Aids for Dogs Sales Value Market Share by Country (2021-2026) Table 65. Global Calming Aids for Dogs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Calming Aids for Dogs Sales Value Market Share by Country (2027-2032) Table 67. Zoetis Company Information Table 68. Zoetis Business Overview Table 69. Zoetis Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Zoetis Calming Aids for Dogs Product Portfolio Table 71. Zoetis Recent Development Table 72. Shangrao Chunyu Technology Company Information Table 73. Shangrao Chunyu Technology Business Overview Table 74. Shangrao Chunyu Technology Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio Table 76. Shangrao Chunyu Technology Recent Development Table 77. Shandong Youmi Le Health Technology Company Information Table 78. Shandong Youmi Le Health Technology Business Overview Table 79. Shandong Youmi Le Health Technology Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio Table 81. Shandong Youmi Le Health Technology Recent Development Table 82. Zatural Company Information Table 83. Zatural Business Overview Table 84. Zatural Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Zatural Calming Aids for Dogs Product Portfolio Table 86. Zatural Recent Development Table 87. Wild One Company Information Table 88. Wild One Business Overview Table 89. Wild One Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Wild One Calming Aids for Dogs Product Portfolio Table 91. Wild One Recent Development Table 92. Vetoquinol Company Information Table 93. Vetoquinol Business Overview Table 94. Vetoquinol Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Vetoquinol Calming Aids for Dogs Product Portfolio Table 96. Vetoquinol Recent Development Table 97. ThunderEase Company Information Table 98. ThunderEase Business Overview Table 99. ThunderEase Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. ThunderEase Calming Aids for Dogs Product Portfolio Table 101. ThunderEase Recent Development Table 102. This Dog's Life Company Information Table 103. This Dog's Life Business Overview Table 104. This Dog's Life Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. This Dog's Life Calming Aids for Dogs Product Portfolio Table 106. This Dog's Life Recent Development Table 107. The Anxious Pet Company Information Table 108. The Anxious Pet Business Overview Table 109. The Anxious Pet Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. The Anxious Pet Calming Aids for Dogs Product Portfolio Table 111. The Anxious Pet Recent Development Table 112. Purina Company Information Table 113. Purina Business Overview Table 114. Purina Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Purina Calming Aids for Dogs Product Portfolio Table 116. Purina Recent Development Table 117. Primo Pup Company Information Table 118. Primo Pup Business Overview Table 119. Primo Pup Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Primo Pup Calming Aids for Dogs Product Portfolio Table 121. Primo Pup Recent Development Table 122. PetHonesty Company Information Table 123. PetHonesty Business Overview Table 124. PetHonesty Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. PetHonesty Calming Aids for Dogs Product Portfolio Table 126. PetHonesty Recent Development Table 127. Pet Remedy Company Information Table 128. Pet Remedy Business Overview Table 129. Pet Remedy Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Pet Remedy Calming Aids for Dogs Product Portfolio Table 131. Pet Remedy Recent Development Table 132. Penelope's Bloom Company Information Table 133. Penelope's Bloom Business Overview Table 134. Penelope's Bloom Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Penelope's Bloom Calming Aids for Dogs Product Portfolio Table 136. Penelope's Bloom Recent Development Table 137. NaturVet Company Information Table 138. NaturVet Business Overview Table 139. NaturVet Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. NaturVet Calming Aids for Dogs Product Portfolio Table 141. NaturVet Recent Development Table 142. Merck Animal Health Company Information Table 143. Merck Animal Health Business Overview Table 144. Merck Animal Health Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Merck Animal Health Calming Aids for Dogs Product Portfolio Table 146. Merck Animal Health Recent Development Table 147. Maxxidog Company Information Table 148. Maxxidog Business Overview Table 149. Maxxidog Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Maxxidog Calming Aids for Dogs Product Portfolio Table 151. Maxxidog Recent Development Table 152. Kradle Company Information Table 153. Kradle Business Overview Table 154. Kradle Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Kradle Calming Aids for Dogs Product Portfolio Table 156. Kradle Recent Development Table 157. Koi CBD Company Information Table 158. Koi CBD Business Overview Table 159. Koi CBD Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Koi CBD Calming Aids for Dogs Product Portfolio Table 161. Koi CBD Recent Development Table 162. King Kanine Company Information Table 163. King Kanine Business Overview Table 164. King Kanine Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. King Kanine Calming Aids for Dogs Product Portfolio Table 166. King Kanine Recent Development Table 167. Heavenly Hounds Company Information Table 168. Heavenly Hounds Business Overview Table 169. Heavenly Hounds Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Heavenly Hounds Calming Aids for Dogs Product Portfolio Table 171. Heavenly Hounds Recent Development Table 172. FOMO Bones Company Information Table 173. FOMO Bones Business Overview Table 174. FOMO Bones Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. FOMO Bones Calming Aids for Dogs Product Portfolio Table 176. FOMO Bones Recent Development Table 177. Extract Labs Company Information Table 178. Extract Labs Business Overview Table 179. Extract Labs Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Extract Labs Calming Aids for Dogs Product Portfolio Table 181. Extract Labs Recent Development Table 182. ElleVet Sciences Company Information Table 183. ElleVet Sciences Business Overview Table 184. ElleVet Sciences Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. ElleVet Sciences Calming Aids for Dogs Product Portfolio Table 186. ElleVet Sciences Recent Development Table 187. Elanco Company Information Table 188. Elanco Business Overview Table 189. Elanco Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. Elanco Calming Aids for Dogs Product Portfolio Table 191. Elanco Recent Development Table 192. Dr. Harvey’s Company Information Table 193. Dr. Harvey’s Business Overview Table 194. Dr. Harvey’s Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Dr. Harvey’s Calming Aids for Dogs Product Portfolio Table 196. Dr. Harvey’s Recent Development Table 197. Ceva Company Information Table 198. Ceva Business Overview Table 199. Ceva Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. Ceva Calming Aids for Dogs Product Portfolio Table 201. Ceva Recent Development Table 202. Boehringer Ingelheim Company Information Table 203. Boehringer Ingelheim Business Overview Table 204. Boehringer Ingelheim Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. Boehringer Ingelheim Calming Aids for Dogs Product Portfolio Table 206. Boehringer Ingelheim Recent Development Table 207. Ark Naturals Company Information Table 208. Ark Naturals Business Overview Table 209. Ark Naturals Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 210. Ark Naturals Calming Aids for Dogs Product Portfolio Table 211. Ark Naturals Recent Development Table 212. Adaptil Company Information Table 213. Adaptil Business Overview Table 214. Adaptil Calming Aids for Dogs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 215. Adaptil Calming Aids for Dogs Product Portfolio Table 216. Adaptil Recent Development Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Calming Aids for Dogs Distributors List Table 220. Calming Aids for Dogs Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Calming Aids for Dogs Product Image Figure 2. Global Calming Aids for Dogs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Calming Aids for Dogs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Calming Aids for Dogs Sales (2021-2032) & (k units) Figure 5. Global Calming Aids for Dogs Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Calming Aids for Dogs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Calming Collars Image Figure 10. Calming Supplements Image Figure 11. Pheromone Sprays Image Figure 12. Anxiety Vests Image Figure 13. Global Calming Aids for Dogs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Calming Aids for Dogs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Calming Aids for Dogs Sales Volume Share by Type (2021-2032) Figure 16. Global Calming Aids for Dogs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Calming Aids for Dogs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Calming Aids for Dogs Sales Value Share by Type (2021-2032) Figure 19. Pet Shop Image Figure 20. Pet Hospitals and Clinics Image Figure 21. Household Image Figure 22. Others Image Figure 23. Global Calming Aids for Dogs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Calming Aids for Dogs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Calming Aids for Dogs Sales Volume Share by Application (2021-2032) Figure 26. Global Calming Aids for Dogs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Calming Aids for Dogs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Calming Aids for Dogs Sales Value Share by Application (2021-2032) Figure 29. Global Calming Aids for Dogs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Calming Aids for Dogs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Calming Aids for Dogs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Calming Aids for Dogs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Calming Aids for Dogs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Calming Aids for Dogs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Calming Aids for Dogs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Calming Aids for Dogs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Calming Aids for Dogs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Calming Aids for Dogs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Calming Aids for Dogs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Calming Aids for Dogs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Calming Aids for Dogs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Calming Aids for Dogs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Calming Aids for Dogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Calming Aids for Dogs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Calming Aids for Dogs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Calming Collars
  • Calming Supplements
  • Pheromone Sprays
  • Anxiety Vests
Applications
  • Pet Shop
  • Pet Hospitals and Clinics
  • Household
  • Others
Companies covered
  • Zoetis
  • Shangrao Chunyu Technology
  • Shandong Youmi Le Health Technology
  • Zatural
  • Wild One
  • Vetoquinol
  • ThunderEase
  • This Dog's Life
  • The Anxious Pet
  • Purina
  • Primo Pup
  • PetHonesty
  • Pet Remedy
  • Penelope's Bloom
  • NaturVet
  • Merck Animal Health
  • Maxxidog
  • Kradle
  • Koi CBD
  • King Kanine
  • Heavenly Hounds
  • FOMO Bones
  • Extract Labs
  • ElleVet Sciences
  • Elanco
  • Dr. Harvey’s
  • Ceva
  • Boehringer Ingelheim
  • Ark Naturals
  • Adaptil

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Calming Aids for Dogs Sales Value (2021-2032)
  4. 1.2.2 Global Calming Aids for Dogs Sales Volume (2021-2032)
  5. 1.2.3 Global Calming Aids for Dogs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Calming Aids for Dogs Market Dynamics
  1. 2.1 Calming Aids for Dogs Industry Trends
  2. 2.2 Calming Aids for Dogs Industry Drivers
  3. 2.3 Calming Aids for Dogs Industry Opportunities and Challenges
  4. 2.4 Calming Aids for Dogs Industry Restraints
3 Calming Aids for Dogs Market by Company
  1. 3.1 Global Calming Aids for Dogs Company Revenue Ranking in 2025
  2. 3.2 Global Calming Aids for Dogs Revenue by Company (2021-2026)
  3. 3.3 Global Calming Aids for Dogs Sales Volume by Company (2021-2026)
  4. 3.4 Global Calming Aids for Dogs Average Price by Company (2021-2026)
  5. 3.5 Global Calming Aids for Dogs Company Ranking (2024-2026)
  6. 3.6 Global Calming Aids for Dogs Company Manufacturing Base and Headquarters
  7. 3.7 Global Calming Aids for Dogs Company Product Type and Application
  8. 3.8 Global Calming Aids for Dogs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Calming Aids for Dogs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Calming Aids for Dogs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Calming Aids for Dogs Market by Type
  1. 4.1 Calming Aids for Dogs Type Introduction
  2. 4.1.1 Calming Collars
  3. 4.1.2 Calming Supplements
  4. 4.1.3 Pheromone Sprays
  5. 4.1.4 Anxiety Vests
  6. 4.2 Global Calming Aids for Dogs Sales Volume by Type
  7. 4.2.1 Global Calming Aids for Dogs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Calming Aids for Dogs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Calming Aids for Dogs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Calming Aids for Dogs Sales Value by Type
  11. 4.3.1 Global Calming Aids for Dogs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Calming Aids for Dogs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Calming Aids for Dogs Sales Value Share by Type (2021-2032)
5 Calming Aids for Dogs Market by Application
  1. 5.1 Calming Aids for Dogs Application Introduction
  2. 5.1.1 Pet Shop
  3. 5.1.2 Pet Hospitals and Clinics
  4. 5.1.3 Household
  5. 5.1.4 Others
  6. 5.2 Global Calming Aids for Dogs Sales Volume by Application
  7. 5.2.1 Global Calming Aids for Dogs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Calming Aids for Dogs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Calming Aids for Dogs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Calming Aids for Dogs Sales Value by Application
  11. 5.3.1 Global Calming Aids for Dogs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Calming Aids for Dogs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Calming Aids for Dogs Sales Value Share by Application (2021-2032)
6 Calming Aids for Dogs Regional Sales and Value Analysis
  1. 6.1 Global Calming Aids for Dogs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Calming Aids for Dogs Sales by Region (2021-2032)
  3. 6.2.1 Global Calming Aids for Dogs Sales by Region: 2021-2026
  4. 6.2.2 Global Calming Aids for Dogs Sales by Region (2027-2032)
  5. 6.3 Global Calming Aids for Dogs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Calming Aids for Dogs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Calming Aids for Dogs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Calming Aids for Dogs Sales Value by Region (2027-2032)
  9. 6.5 Global Calming Aids for Dogs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Calming Aids for Dogs Sales Value (2021-2032)
  12. 6.6.2 North America Calming Aids for Dogs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Calming Aids for Dogs Sales Value (2021-2032)
  15. 6.7.2 Europe Calming Aids for Dogs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Calming Aids for Dogs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Calming Aids for Dogs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Calming Aids for Dogs Sales Value (2021-2032)
  21. 6.9.2 South America Calming Aids for Dogs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Calming Aids for Dogs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Calming Aids for Dogs Sales Value Share by Country, 2025 VS 2032
7 Calming Aids for Dogs Country-level Sales and Value Analysis
  1. 7.1 Global Calming Aids for Dogs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Calming Aids for Dogs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Calming Aids for Dogs Sales by Country (2021-2032)
  4. 7.3.1 Global Calming Aids for Dogs Sales by Country (2021-2026)
  5. 7.3.2 Global Calming Aids for Dogs Sales by Country (2027-2032)
  6. 7.4 Global Calming Aids for Dogs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Calming Aids for Dogs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Calming Aids for Dogs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Calming Aids for Dogs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Calming Aids for Dogs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Calming Aids for Dogs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Calming Aids for Dogs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Shangrao Chunyu Technology
  8. 8.2.1 Shangrao Chunyu Technology Company Information
  9. 8.2.2 Shangrao Chunyu Technology Business Overview
  10. 8.2.3 Shangrao Chunyu Technology Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio
  12. 8.2.5 Shangrao Chunyu Technology Recent Developments
  13. 8.3 Shandong Youmi Le Health Technology
  14. 8.3.1 Shandong Youmi Le Health Technology Company Information
  15. 8.3.2 Shandong Youmi Le Health Technology Business Overview
  16. 8.3.3 Shandong Youmi Le Health Technology Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio
  18. 8.3.5 Shandong Youmi Le Health Technology Recent Developments
  19. 8.4 Zatural
  20. 8.4.1 Zatural Company Information
  21. 8.4.2 Zatural Business Overview
  22. 8.4.3 Zatural Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zatural Calming Aids for Dogs Product Portfolio
  24. 8.4.5 Zatural Recent Developments
  25. 8.5 Wild One
  26. 8.5.1 Wild One Company Information
  27. 8.5.2 Wild One Business Overview
  28. 8.5.3 Wild One Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wild One Calming Aids for Dogs Product Portfolio
  30. 8.5.5 Wild One Recent Developments
  31. 8.6 Vetoquinol
  32. 8.6.1 Vetoquinol Company Information
  33. 8.6.2 Vetoquinol Business Overview
  34. 8.6.3 Vetoquinol Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vetoquinol Calming Aids for Dogs Product Portfolio
  36. 8.6.5 Vetoquinol Recent Developments
  37. 8.7 ThunderEase
  38. 8.7.1 ThunderEase Company Information
  39. 8.7.2 ThunderEase Business Overview
  40. 8.7.3 ThunderEase Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ThunderEase Calming Aids for Dogs Product Portfolio
  42. 8.7.5 ThunderEase Recent Developments
  43. 8.8 This Dog's Life
  44. 8.8.1 This Dog's Life Company Information
  45. 8.8.2 This Dog's Life Business Overview
  46. 8.8.3 This Dog's Life Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 This Dog's Life Calming Aids for Dogs Product Portfolio
  48. 8.8.5 This Dog's Life Recent Developments
  49. 8.9 The Anxious Pet
  50. 8.9.1 The Anxious Pet Company Information
  51. 8.9.2 The Anxious Pet Business Overview
  52. 8.9.3 The Anxious Pet Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 The Anxious Pet Calming Aids for Dogs Product Portfolio
  54. 8.9.5 The Anxious Pet Recent Developments
  55. 8.10 Purina
  56. 8.10.1 Purina Company Information
  57. 8.10.2 Purina Business Overview
  58. 8.10.3 Purina Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Purina Calming Aids for Dogs Product Portfolio
  60. 8.10.5 Purina Recent Developments
  61. 8.11 Primo Pup
  62. 8.11.1 Primo Pup Company Information
  63. 8.11.2 Primo Pup Business Overview
  64. 8.11.3 Primo Pup Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Primo Pup Calming Aids for Dogs Product Portfolio
  66. 8.11.5 Primo Pup Recent Developments
  67. 8.12 PetHonesty
  68. 8.12.1 PetHonesty Company Information
  69. 8.12.2 PetHonesty Business Overview
  70. 8.12.3 PetHonesty Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 PetHonesty Calming Aids for Dogs Product Portfolio
  72. 8.12.5 PetHonesty Recent Developments
  73. 8.13 Pet Remedy
  74. 8.13.1 Pet Remedy Company Information
  75. 8.13.2 Pet Remedy Business Overview
  76. 8.13.3 Pet Remedy Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Pet Remedy Calming Aids for Dogs Product Portfolio
  78. 8.13.5 Pet Remedy Recent Developments
  79. 8.14 Penelope's Bloom
  80. 8.14.1 Penelope's Bloom Company Information
  81. 8.14.2 Penelope's Bloom Business Overview
  82. 8.14.3 Penelope's Bloom Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Penelope's Bloom Calming Aids for Dogs Product Portfolio
  84. 8.14.5 Penelope's Bloom Recent Developments
  85. 8.15 NaturVet
  86. 8.15.1 NaturVet Company Information
  87. 8.15.2 NaturVet Business Overview
  88. 8.15.3 NaturVet Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 NaturVet Calming Aids for Dogs Product Portfolio
  90. 8.15.5 NaturVet Recent Developments
  91. 8.16 Merck Animal Health
  92. 8.16.1 Merck Animal Health Company Information
  93. 8.16.2 Merck Animal Health Business Overview
  94. 8.16.3 Merck Animal Health Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Merck Animal Health Calming Aids for Dogs Product Portfolio
  96. 8.16.5 Merck Animal Health Recent Developments
  97. 8.17 Maxxidog
  98. 8.17.1 Maxxidog Company Information
  99. 8.17.2 Maxxidog Business Overview
  100. 8.17.3 Maxxidog Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Maxxidog Calming Aids for Dogs Product Portfolio
  102. 8.17.5 Maxxidog Recent Developments
  103. 8.18 Kradle
  104. 8.18.1 Kradle Company Information
  105. 8.18.2 Kradle Business Overview
  106. 8.18.3 Kradle Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Kradle Calming Aids for Dogs Product Portfolio
  108. 8.18.5 Kradle Recent Developments
  109. 8.19 Koi CBD
  110. 8.19.1 Koi CBD Company Information
  111. 8.19.2 Koi CBD Business Overview
  112. 8.19.3 Koi CBD Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Koi CBD Calming Aids for Dogs Product Portfolio
  114. 8.19.5 Koi CBD Recent Developments
  115. 8.20 King Kanine
  116. 8.20.1 King Kanine Company Information
  117. 8.20.2 King Kanine Business Overview
  118. 8.20.3 King Kanine Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 King Kanine Calming Aids for Dogs Product Portfolio
  120. 8.20.5 King Kanine Recent Developments
  121. 8.21 Heavenly Hounds
  122. 8.21.1 Heavenly Hounds Company Information
  123. 8.21.2 Heavenly Hounds Business Overview
  124. 8.21.3 Heavenly Hounds Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Heavenly Hounds Calming Aids for Dogs Product Portfolio
  126. 8.21.5 Heavenly Hounds Recent Developments
  127. 8.22 FOMO Bones
  128. 8.22.1 FOMO Bones Company Information
  129. 8.22.2 FOMO Bones Business Overview
  130. 8.22.3 FOMO Bones Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 FOMO Bones Calming Aids for Dogs Product Portfolio
  132. 8.22.5 FOMO Bones Recent Developments
  133. 8.23 Extract Labs
  134. 8.23.1 Extract Labs Company Information
  135. 8.23.2 Extract Labs Business Overview
  136. 8.23.3 Extract Labs Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Extract Labs Calming Aids for Dogs Product Portfolio
  138. 8.23.5 Extract Labs Recent Developments
  139. 8.24 ElleVet Sciences
  140. 8.24.1 ElleVet Sciences Company Information
  141. 8.24.2 ElleVet Sciences Business Overview
  142. 8.24.3 ElleVet Sciences Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 ElleVet Sciences Calming Aids for Dogs Product Portfolio
  144. 8.24.5 ElleVet Sciences Recent Developments
  145. 8.25 Elanco
  146. 8.25.1 Elanco Company Information
  147. 8.25.2 Elanco Business Overview
  148. 8.25.3 Elanco Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Elanco Calming Aids for Dogs Product Portfolio
  150. 8.25.5 Elanco Recent Developments
  151. 8.26 Dr. Harvey’s
  152. 8.26.1 Dr. Harvey’s Company Information
  153. 8.26.2 Dr. Harvey’s Business Overview
  154. 8.26.3 Dr. Harvey’s Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Dr. Harvey’s Calming Aids for Dogs Product Portfolio
  156. 8.26.5 Dr. Harvey’s Recent Developments
  157. 8.27 Ceva
  158. 8.27.1 Ceva Company Information
  159. 8.27.2 Ceva Business Overview
  160. 8.27.3 Ceva Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Ceva Calming Aids for Dogs Product Portfolio
  162. 8.27.5 Ceva Recent Developments
  163. 8.28 Boehringer Ingelheim
  164. 8.28.1 Boehringer Ingelheim Company Information
  165. 8.28.2 Boehringer Ingelheim Business Overview
  166. 8.28.3 Boehringer Ingelheim Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 Boehringer Ingelheim Calming Aids for Dogs Product Portfolio
  168. 8.28.5 Boehringer Ingelheim Recent Developments
  169. 8.29 Ark Naturals
  170. 8.29.1 Ark Naturals Company Information
  171. 8.29.2 Ark Naturals Business Overview
  172. 8.29.3 Ark Naturals Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  173. 8.29.4 Ark Naturals Calming Aids for Dogs Product Portfolio
  174. 8.29.5 Ark Naturals Recent Developments
  175. 8.30 Adaptil
  176. 8.30.1 Adaptil Company Information
  177. 8.30.2 Adaptil Business Overview
  178. 8.30.3 Adaptil Calming Aids for Dogs Sales, Value and Gross Margin (2021-2026)
  179. 8.30.4 Adaptil Calming Aids for Dogs Product Portfolio
  180. 8.30.5 Adaptil Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Calming Aids for Dogs Value Chain Analysis
  2. 9.1.1 Calming Aids for Dogs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Calming Aids for Dogs Sales Mode & Process
  6. 9.2 Calming Aids for Dogs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Calming Aids for Dogs Distributors
  9. 9.2.3 Calming Aids for Dogs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst